The direct Myc inhibition seems difficult, and strategies used to target Myc include approaches focused on tumor cell metabolic abnormalities induced by Myc overexpression [43] or synthetic-lethal strategy [10,44]. The gene discussed is MYC; the disease is neoplasm.